Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al.

por de Miranda Santos, Isabel Kinney Ferreira, de Barros Cardoso, Cristina Ribeiro
Publicado 2021

CCR5 Controls Immune and Metabolic Functions during Toxoplasma gondii Infection

por Bonfá, Giuliano, Benevides, Luciana, Souza, Maria do Carmo, Fonseca, Denise Morais, Mineo, Tiago Wilson Patriarca, Rossi, Marcos Antônio, Silva, Neide Maria, Silva, João Santana, de Barros Cardoso, Cristina Ribeiro
Publicado 2014

COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes

por Fraga-Silva, Thais Fernanda de Campos, Maruyama, Sandra Regina, Sorgi, Carlos Arterio, Russo, Elisa Maria de Sousa, Fernandes, Ana Paula Morais, de Barros Cardoso, Cristina Ribeiro, Faccioli, Lucia Helena, Dias-Baruffi, Marcelo, Bonato, Vânia Luiza Deperon
Publicado 2021